Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.43B
Enterprise Value2.36B
P/E Ratio21.67
PEG Ratio0.65
Price/Sales Ratio2.1
Price/Book Ratio1.87
Enterprise/Revenue2.16
Enterprise/EBITDA10.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.09
Operating Margin0.11
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.09

Income Statement

Revenue1.05B
Revenue/Share13.26
Gross Profit239.39M
EBITDA183.69M
Net Income99.85M
Diluted EPS1.21

Balance Sheet

Total Cash461.56M
Total Cash/Share5.69
Total Debt516.4M
Total Debt/Equity0.44
Current Ratio1.23
Book Value Per Share14.46

Price History

52-Week Change-1.25
52-Week High37.99
52-Week Low24.69
Moving Average 50 Days29.95
Moving Average 200 Days31.49

Statistics

Average Volume2.48M
Shares Outstanding84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.6
Trailing Annual Dividend Yield2.23
Payout Ratio0.53
Last Split Factor7:5
Last Split DateNovember 14, 2023
AD